Clinical Trial Using Monoclonal Immunoconjugates

Goodman, Gary E.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: Division of Cancer Treatment (NCI)
• Type: Research and Development Contracts (N01)
• Project #: N01CM047668-001005
• Application #: 3612133
• Project Start: 1984-09-29
• Budget Start: 1987-06-30
• Budget End: 1987-06-30
• Fiscal Year: 1987

Institution

• Name: Fred Hutchinson Cancer Research Center
• DUNS #: 075524595
• City: Seattle
• State: WA
• Country: United States
• Zip Code: 98109

Publications

Lindgren, C G; Thompson, J A; Higuchi, C M et al. (1993) Growth and autologous tumor lysis by tumor-infiltrating lymphocytes from metastatic melanoma expanded in interleukin-2 or interleukin-2 plus interleukin-4. J Immunother Emphasis Tumor Immunol 14:322-8

Thompson, J A; Shulman, K L; Benyunes, M C et al. (1992) Prolonged continuous intravenous infusion interleukin-2 and lymphokine-activated killer-cell therapy for metastatic renal cell carcinoma. J Clin Oncol 10:960-8

Treisman, J; Higuchi, C M; Thompson, J A et al. (1990) Enhancement by interleukin 4 of interleukin 2- or antibody-induced proliferation of lymphocytes from interleukin 2-treated cancer patients. Cancer Res 50:1160-4

Higuchi, C M; Thompson, J A; Lindgren, C G et al. (1989) Induction of lymphokine-activated killer activity by interleukin 4 in human lymphocytes preactivated by interleukin 2 in vivo or in vitro. Cancer Res 49:6487-92